1-11 of 11
Marek Kielbinski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3 -ITD + normal karyotype AML patients

Free
Clinical Trials & Observations
Marta Libura, Sebastian Giebel, Beata Piatkowska-Jakubas, Marta Pawelczyk, Izabella Florek, Karolina Matiakowska, Bozena Jazwiec, Katarzyna Borg, Iwona Solarska, Magdalena Zawada, Sylwia Czekalska, Jolanta Libura, Malgorzata Jakobczyk, Karolina Karabin, Monika Paluszewska, Malgorzata Calbecka, Justyna Gajkowska-Kulik, Grazyna Gadomska, Marek Kielbinski, Anna Ejduk, Dariusz Kata, Sebastian Grosicki, Agnieszka Wierzbowska, Slawomira Kyrcz-Krzemien, Krzysztof Warzocha, Kazimierz Kuliczkowski, Aleksander Skotnicki, Jerzy Holowiecki, Wieslaw Wiktor Jedrzejczak, Olga Haus
Journal: Blood
Blood (2016) 127 (3): 360–362.
https://doi.org/10.1182/blood-2015-08-662130
Published: 2016
Includes: Supplemental data
Journal Articles

ICOS Gene Polymorphisms In B-Cell Chronic Lymphocytic Leukemia In a Polish Population.

Free
Irena Frydecka, Lidia Karabon, Anna Jedynak, Anna Tomkiewicz, Edyta Pawlak, Dariusz Wolowiec, Marek Kielbinski, Kazimierz Kuliczkowski, Dariusz Woszczyk, Tomasz Wrobel, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4614.
https://doi.org/10.1182/blood.V116.21.4614.4614
Published: 2010
Journal Articles

Cladribine in Combination with Standard Daunorubicine and Cytarabine (DAC) as a Remission Induction Treatment Improves the Overall Survival in Untreated Adults with AML Aged < 60 y Contrary to Combination Including Fludarabine (DAF): A Multicenter, Randomized, Phase III PALG AML 1/2004 DAC/DAF/DA Study in 673 Patients-A Final Update.

Free
Jerzy Holowiecki, Prof., Sebastian Grosicki, MD, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Aleksander B Skotnicki, Andrzej Hellmann, MD, PhD, DSc, Tadeusz Robak, Kazimierz Sulek, Anna Dmoszynska, Janusz Kloczko, Wieslaw Wiktor Jedrzejczak, Barbara Zdziarska, Krzysztof Warzocha, MD, PhD, Krystyna Maria Zawilska, Sebastian Giebel, Mieczyslaw Komarnicki, Marek Kielbinski, Beata Piatkowska-Jakubas, Agnieszka Wierzbowska, Olga Haus, Beata Stella-Holowiecka, Malgorzata Krawczyk-Kulis, Malgorzata Wach, Tomasz Czerw, Anna Ejduk
Journal: Blood
Blood (2009) 114 (22): 2055.
https://doi.org/10.1182/blood.V114.22.2055.2055
Published: 2009
Journal Articles

KIR Genes and Their HLA-C Ligands in B-Cell Chronic Lymphocytic Leukemia in a Polish Population.

Free
Irena Frydecka, Anna Jedynak, Lidia Karabon, Edyta Pawlak, Anna Tomkiewicz, Marek Kielbinski, Dariusz Woszczyk, Dariusz Wolowiec, Kazimierz Kuliczkowski
Journal: Blood
Blood (2009) 114 (22): 4402.
https://doi.org/10.1182/blood.V114.22.4402.4402
Published: 2009
Journal Articles

Addition of Cladribine to the Standard Daunorubicine - Cytarabine (DA 3+7) Remission Induction Protocol (DAC) Contrary to Adjunct of Fludarabine (DAF) Improves the Overall Survival in Untreated Adults with Acute Myeloid Leukemia Aged up to 60 Y: A Multicenter, Randomized, Phase III PALG AML 1/2004 DAF/DAC/DA Study in 673 Patients

Free
Jerzy Holowiecki, Sebastian Grosicki, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Aleksander B. Skotnicki, Andrzej Hellmann, MD, PhD, Tadeusz Robak, MD, PhD, Kazimierz Sulek, Anna Dmoszynska, Janusz Kloczko, Wieslaw Wiktor Jedrzejczak, Barbara Zdziarska, Krzysztof Warzocha, Krystyna Zawilska, Marek Kielbinski, Beata Piatkowska-Jakubas, Agnieszka Wierzbowska, Olga Haus, Beata Stella-Holowiecka, Malgorzata Krawczyk-Kulis, Malgorzata Wach, Anna Ejduk
Journal: Blood
Blood (2008) 112 (11): 133.
https://doi.org/10.1182/blood.V112.11.133.133
Published: 2008
Journal Articles

The Reduction of Leukemic Blasts In Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia: The Results of Multicenter, Prospective Polish Adult Leukemia Group Study.

Free
Jerzy Holowiecki, Sebastian Grosicki, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Marek Kielbinski, Aleksander B. Skotnicki, Beata Piatkowska-Jakubas, Andrzej Hellmann, MD, PhD, Agnieszka Wierzbowska, Marek Seweryn, Beata Stella-Holowiecka, Maria Sadus-Wojciechowska
Journal: Blood
Blood (2008) 112 (11): 1950.
https://doi.org/10.1182/blood.V112.11.1950.1950
Published: 2008
Journal Articles

Significance of BAALC , MN 1, ERG , CEBP a Gene Expression as New Prognostic Factors, in the Context of Other Molecular Markers in Intermediate Risk AML Group According to Cytogenetics, Including Patients Younger Than 60 Years

Free
Marta Antonina Libura, MD, PhD, Beata Piatkowska-Jakubas, Olga Haus, Izabela Florek, Bozena Jazwiec, PhD, Krystyna Soszynska, PhD, Zoriana Salamanchuk, PhD, Malgorzata Jakobczyk, Szymon Fornagiel, Tomasz Sacha, Marek Kielbinski, Kazimierz Kuliczkowski, Ewa Duszenko, Anna Jaskowiec, Barbara Mucha, Katarzyna Skonieczna, Aleksander Skotnicki
Journal: Blood
Blood (2008) 112 (11): 4855.
https://doi.org/10.1182/blood.V112.11.4855.4855
Published: 2008
Journal Articles

The Reduction of Leukemic Blasts in Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia; the Results of Multicenter, Prospective Polish Adult Leukemia Group Trial.

Free
Jerzy Holowiecki, Sebastian Grosicki, MD, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Marek Kielbinski, MD, Aleksander B. Skotnicki, Beata Jakubas, MD, Andrzej Hellmann, Tadeusz Robak, Marek J. Seweryn, MD, Beata Stella-Holowiecka, MD, Maria Sadus-Wojciechowska, MD
Journal: Blood
Blood (2007) 110 (11): 4375.
https://doi.org/10.1182/blood.V110.11.4375.4375
Published: 2007
Journal Articles

Clinical Relevance of Multidrug Resistance Proteins Expression in Patients with De Novo Acute Myeloid Leukaemia.

Free
Maria Podolak-Dawidziak, Danuta Dus, Marek Kielbinski, Maria Paprocka, Olga Haus, Malgorzata Kuliszkiewicz-Janus, Kazimierz Kuliczkowski
Journal: Blood
Blood (2006) 108 (11): 4363.
https://doi.org/10.1182/blood.V108.11.4363.4363
Published: 2006
Journal Articles

Is CD94/NKG2A a Novel Target for Lymphoid Malignancies Immunotherapy?.

Free
Donata Urbaniak-Kujda, PhD, Jaroslaw Dybko, MD, Iwona Prajs, MSci, Marek Kielbinski, PhD, Beata Tomaszewska-Toporska, MD, Katarzyna Kapelko-Slowik, PhD, Kazimierz Kuliczkowski, PhD
Journal: Blood
Blood (2006) 108 (11): 4650.
https://doi.org/10.1182/blood.V108.11.4650.4650
Published: 2006
Journal Articles

The Clinical Significance of the Multidrug Resistance Proteins Expression in Patients with Acute Myeloid Leukemia.

Free
Maria Podolak-Dawidziak, Danuta Dus, Marek Kielbinski, Maria Paprocka, Malgorzata Kuliszkowicz-Janus, Kazimierz Kuliczkowski
Journal: Blood
Blood (2004) 104 (11): 4411.
https://doi.org/10.1182/blood.V104.11.4411.4411
Published: 2004